| J9271 | Injection, pembrolizumab, 1 mg | 13,500 | $40 | $580.5K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 330 | $130 | $44K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 310 | $100 | $31.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 240 | $90 | $22.3K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 290 | $70 | $20.4K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 9,700 | $1 | $19.4K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 280 | $60 | $17.5K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 15,000 | $1 | $15K |
| J0185 | Injection, aprepitant, 1 mg | 11,310 | $1 | $11.3K |
| M0010 | Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 160 | $70 | $11.2K |